Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis
about
Monoclonal antibodies against peptidorhamnomannans of Scedosporium apiospermum enhance the pathogenicity of the fungusCryptococcal interactions with the host immune system.Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of Cryptococcus neoformans through different receptorsEfficacy of NS-718, a novel lipid nanosphere-encapsulated amphotericin B, against Cryptococcus neoformansCharacterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsuleBivalency is required for anticapsular monoclonal antibodies to optimally suppress activation of the alternative complement pathway by the Cryptococcus neoformans capsule.Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis.Capsular reactions of Cryptococcus neoformans with polyspecific and oligospecific polyclonal anticapsular antibodiesBinding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophagesHuman immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformansNew concepts in antibody-mediated immunity.Do kinetics of the humoral response to Cryptococcus neoformans proteins during murine cryptococcosis reflect outcome?Biological activity of a mouse-human chimeric immunoglobulin G2 antibody to Cryptococcus neoformans polysaccharide.
P2860
Q27306696-3967C130-0D53-4DFD-A8BD-BEF6D0698CC3Q30387948-240EC908-BCB7-497B-9BED-5C46CFE2660AQ33562297-F3AFFFBC-3F5E-4FD0-B9AD-19CF4BD6A9D2Q33694175-BDCFBDBC-3225-489D-9C35-D4FCD8237658Q33752366-AE428A3A-553B-4D48-B4A7-086F20D104B5Q33752377-4E3ABB17-46C3-4B7B-A721-543660E08CE7Q33857658-CDF77383-918B-4B61-B51F-3410B1310826Q34006122-866AADE3-DBAA-4B3F-BDE6-151983D769C8Q34301177-FA5444E5-C0F1-48BD-AB2C-D819FA7390ACQ35689463-FE15F670-DADE-4A37-805A-494840CEBC54Q35923662-5CD2FD86-F4CE-4906-B00A-FA66C4E4FDA0Q35926507-69C47EF2-9360-450C-B287-5875722EE1A7Q39516572-026BC8AB-CEFB-4816-B8B4-4BAB7BF29068Q39625324-E19F7DFE-2BE5-463A-8C36-189E39AB30BF
P2860
Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Acute lethal toxicity followin ...... tment of murine cryptococcosis
@ast
Acute lethal toxicity followin ...... tment of murine cryptococcosis
@en
type
label
Acute lethal toxicity followin ...... tment of murine cryptococcosis
@ast
Acute lethal toxicity followin ...... tment of murine cryptococcosis
@en
prefLabel
Acute lethal toxicity followin ...... tment of murine cryptococcosis
@ast
Acute lethal toxicity followin ...... tment of murine cryptococcosis
@en
P2093
P2860
P50
P1476
Acute lethal toxicity followin ...... tment of murine cryptococcosis
@en
P2093
A M Schlageter
J S Roberts
L C Weinhold
P2860
P304
P407
P577
1997-05-01T00:00:00Z